SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia surges on raising Rs 100 crore through commercial papers

12 Dec 2024 Evaluate

Jubilant Ingrevia is currently trading at Rs. 871.65, up by 21.85 points or 2.57% from its previous closing of Rs. 849.80 on the BSE.

The scrip opened at Rs. 851.95 and has touched a high and low of Rs. 884.95 and Rs. 837.60 respectively. So far 56023 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 884.95 on 12-Dec-2024 and a 52 week low of Rs. 421.60 on 05-Feb-2024.

Last one week high and low of the scrip stood at Rs. 884.95 and Rs. 764.50 respectively. The current market cap of the company is Rs. 13872.59 crore.

The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 22.68% and 25.85% respectively.

Jubilant Ingrevia has raised Rs 100 crore through Commercial Papers (CPs).  The maturity of the said Commercial Papers will be on February 24, 2025. Tenure of the instrument is 75 days. The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches.

The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 200 crore.

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.


Jubilant Ingrevia Share Price

678.80 19.40 (2.94%)
22-Apr-2026 11:25 View Price Chart
Peers
Company Name CMP
BASF India 3716.30
Tata Chemicals 708.35
SRF 2497.80
Pidilite Inds. 1406.55
Deepak Nitrite 1701.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×